Dual Targeted Therapy for the Management of Inflammatory Bowel Disease. | J Clin Gastroenterol;55(8): 661-666, 2021 09 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Dual Targeted Therapy for the Management of Inflammatory Bowel Disease.

Haider, Mahnur; Lashner, Bret.

Affiliation

Haider M; Section of Internal Medicine and Geriatrics, Tulane University, New Orleans, LA.
Lashner B; Department of Gastroenterology and Hepatology, Cleveland Clinic, OH.

J Clin Gastroenterol ; 55(8): 661-666, 2021 09 01.

Article in En | MEDLINE | ID: mdl-34238847

Subject(s)

Colitis; Inflammatory Bowel Diseases; Anti-Inflammatory Agents/adverse effects; Humans; Inflammatory Bowel Diseases/drug therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis Type of study: Clinical_trials Limits: Humans Language: En Journal: J Clin Gastroenterol Year: 2021 Document type: Article Affiliation country: LAOS

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis Type of study: Clinical_trials Limits: Humans Language: En Journal: J Clin Gastroenterol Year: 2021 Document type: Article Affiliation country: LAOS